TREELINE
LIVE

Serial Number

99068514

Owner

Treeline Biosciences, Inc.

Attorney

Caitlin R. Byczko

Filing Date

Mar 5, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TREELINE Trademark

Serial Number: 99068514

TREELINE is a trademark filed by Treeline Biosciences, Inc. on March 5, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Treeline Biosciences, Inc. (6 trademarks)

Stamford, CT 06901

Entity Type: 03

Trademark Details

Filing Date

March 5, 2025

Registration Date

Not Registered

Published for Opposition

September 16, 2025

Goods & Services

pharmaceutical products, namely, preparations for the prevention and treatment of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders

pharmaceutical research and development in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders; medical, pharmaceutical, and scientific research in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders; medical, pharmaceutical, and scientific research in the field of biomarkers for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders; clinical research and testing services not for medical diagnostic purposes in the field of cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosing, preventing, and treating diseases and disorders, namely cancer, carcinomas, sarcomas, myelomas, lymphomas, autoimmune diseases and disorders, immunologic-based diseases and disorders, neurodegenerative diseases and disorders, inflammatory diseases and disorders, immune diseases and disorders, neurological diseases and disorders, dermatological diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 12, 2026 EXRA
SOU EXTENSION 1 GRANTED
May 11, 2026 EX1G
SOU EXTENSION 1 FILED
May 11, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
May 11, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 10, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 13, 2025 CNSA
ASSIGNED TO EXAMINER
Aug 7, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 5, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2025 NWOS
NEW APPLICATION ENTERED
Mar 5, 2025 NWAP